FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/06/025871 [Registered on: 15/06/2020] Trial Registered Prospectively
Last Modified On: 03/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to observe additional effect of ayurvedic treatment on Autism Spectrum Disorder in Children 
Scientific Title of Study   Add on effect of selected ayurvedic treatment modalities in the management of Autism Spectrum Disorder in Children  
Trial Acronym  ASD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Snehal Vinayak kale 
Designation  Assistant Professor (YCAMC Aurangabad) PhD scholar (Parul University) 
Affiliation  Yashwantrao Chavan Ayurved medical Collage and Hospital Aurangabad Maharashtra 
Address  Room No 12 Department of Kaumarbhritya (Balroga) Yashwantrao Chavan Ayurved Hospital Aurangabad Maharashtra 431007 Aurangabad MAHARASHTRA
Room No 12 Department of Kaumarbhritya (Balroga) Yashwantrao Chavan Ayurved Hospital Aurangabad Maharashtra 431007 Aurangabad MAHARASHTRA
Aurangabad
MAHARASHTRA
431007
India 
Phone  8956072783  
Fax    
Email  snehalvkale088@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rajanish Meti 
Designation  Professor (Kaumarbhritya department) (Parul Institute of Ayurveda, Parul University) 
Affiliation  Parul Institute of Ayurveda ,Parul University 
Address  Room No 103 Department of Kaumarbhritya (Balroga) Parul Ayurveda Hospital, Parul University,P.O.Limda, Ta.Waghodia, Dist.Vadodara
Room No 103 Department of Kaumarbhritya (Balroga) Parul Ayurveda Hospital, Parul University,P.O.Limda, Ta.Waghodia, Dist.Vadodara
Vadodara
GUJARAT
391760
India 
Phone  9986660145  
Fax    
Email  rajanishsm@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Snehal Vinayak kale 
Designation  Assistant Professor (YCAMC Aurangabad) PhD scholar (Parul University) 
Affiliation  Yashwantrao Chavan Ayurved medical Collage and Hospital Aurangabad Maharashtra 
Address  Room No 12 Department of Kaumarbhritya (Balroga) Yashwantrao Chavan Ayurved Hospital Aurangabad Maharashtra 431007 Aurangabad MAHARASHTRA
Room No 12 Department of Kaumarbhritya (Balroga) Yashwantrao Chavan Ayurved Hospital Aurangabad Maharashtra 431007 Aurangabad MAHARASHTRA
Aurangabad
MAHARASHTRA
431007
India 
Phone  8956072783  
Fax    
Email  snehalvkale088@gmail.com  
 
Source of Monetary or Material Support  
Shiva Trusts Yashwantrao Chavan Ayurved Medical Collage and Hospital Aurangabad Maharashtra 431007  
Parul University P.O Limda, Ta. Waghodia-391760 Dist. Vadodara, Gujarat 
 
Primary Sponsor  
Name  Dr Snehal Vinayak Kale 
Address  Staff Quarter of Shiva Trusts Yashwantrao Chavan Ayurved Medical Collage and Hospital Aurangabad Maharashtra 431007  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Parul University  Parul University, P.O. Limda, Ta. Waghodia-391760, Dist. Vadodara, Gujarat 
Yashwantrao Chavan Ayurved Medical Collage and Hospital Aurangabad  Shiva Trusts Yashwantrao Chavan Ayurved Medical Collage and Hospital Aurangabad Maharashtra 431007  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Snehal Vinayak Kale  Yashwantrao Chavan Ayurved Hospital Aurangabad  Room No 12 Department of Kaumarbhritya (Balroga) Yashwantrao Chavan Ayurved Hospital Aurangabad Maharashtra 431007
Aurangabad
MAHARASHTRA 
8956072783

snehalvkale088@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Parul Institute of Ayurved-Institutional Ethics Committee for Human Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F840||Autistic disorder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Non Pharmacological therapies (Applied Behavioral Analysis)   from 1st day to 180th day 
Intervention  Non Pharmacological therapies (Applied Behavioral Analysis),Maha Paishachika Ghrita,Brahmi Ghrita ,Ksheer Bala taila,Ashwasana Chikitsa  Non Pharmacological therapies (Applied Behavioral Analysis) from 1st day to 180th day, Maha Paishachika Ghrita 3-16 grams (3-16 years) BD Oral from 91th day to 180th day, Brahmi Ghrita 2 drops in each nostril OD Nasal Instillation from 91th day to 180th day, Ksheer Bala taila 10-20 ml OD Shiro Abhyanga from 91th day to 180th day, Ksheer Bala taila 10-20 ml OD Pada Abhyanga from 91th day to 180th day, Ashwasana Chikitsa Once in a month from 91th day to 180th day 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  Fulfilling the diagnostic Criteria of Autism Spectrum Disorder according to
-Diagnostic and Statistical Manual of Mental disorders Fifth edition (DSM-5TM)(299.00)
-Childhood Autism Rating ScaleTM Second edition (CARSTM2)
-Indian Scale for Assessment of Autism (ISAA)
Parents/ Guardian willing to give informed written consent to participate in the study
 
 
ExclusionCriteria 
Details  Children below 3 years and above 16 years
Presence of other organic or psychotic neurological disorder
Hearing and visual impairment, Multiple disabilities
Patients with acute and chronic systemic illness such as renal diseases, Hepatic dysfunction, Juvenile diabetes mellitus, malignancy, etc
Progressive and non progressive neuromuscular disorders, Known neurodegenerative disorder
Hypoxic Ischemic Encephalopathy (HIE)
Endocrinal disorders, Protein Energy Malnutrition (PEM),etc
Children taking anti-epileptic and anti-psychotic drugs 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in clinical features of Autism Spectrum Disorder assessed by 1.Autism Treatment Evaluation Checklist (ATEC)
2.Childhood Autism Rating Scale TM Second edition (CARSTM2)
3.Indian Scale for Assessment of Autism (ISAA)
 

Baseline 0 day and 90 days and End of treatment 180 days 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in the quality of life of Parents
 
Baseline 0 day and 90 days and End of treatment 180 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/07/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This study is a Randomized parallel group open label clinical trial to assess the clinical efficacy of Ayurvedic treatment modalities in the Management of Autism Spectrum Disorder in Children. For that Mahapaishachik Ghrita will be orally administered 3-16 gm (as per age of child of 3-16 years) twice daily with luke warm water or milk for 3 months, Nasal instillation (Nasya) of  Brahmi Ghrita 2 drops in each nostril once daily for 3 months, External application of oil over head (Shiroabhyanga) with Ksheer Bala Taila (10-20 ml) for 10 minutes for 3 months, Ayurvedic foot massage (Padabhyanga) with Ksheer Bala Taila (10-20 ml) for 10 minutes (5 minutes on each foot) will be done before going to bed for 3 months along with Non Pharmacological therapies in children suffering from Autism Spectrum Disorder. 

To keep the transparency of distinguishing the exact effect of special treatment subject in trial group will be divided into two phases and treated i.e. Control group with only Non Pharmacological therapies for 6 months while Trial group treated with Non Pharmacological therapies for first 3 months (Phase I) and with Ayurvedic treatment modalities along with Non Pharmacological therapies for next 3 months (Phase II). 

The primary outcome is reduction in the clinical features of Autism Spectrum Disorder and the secondary outcome will be changes in the quality of life of parents at 90 days and 180 days.



 
Close